Skip to main content

Table 4 Antibiotic resistance in Gram-negative isolates of BSI

From: Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study

Antibiotics

A. baumannii, % resistant (n = 51)

K. pneumoniae, % resistant (n = 41)

P. aeruginosa, % resistant (n = 22)

Amikacin

75.0

52.8

45.0

Ceftazidime

95.0

88.9

30.0

Cefepime

95.0

80.6

65.0

Ciprofloxacin

95.0

86.1

50.0

Levofloxacin

72.5

80.6

55.0

Imipenem

95.0

77.8

75.0

Meropenem

95.0

77.8

75.0

Cefoperazone-Sulbactam

72.5

88.9

80.0

Piperacillin-Tazobactam

95.0

80.6

80.0

Tigecycline

11.4 (n = 45)

24.0 (n = 29)

Polymyxin B

0.0 (n = 21)

0.0 (n = 18)

0.0 (n = 9)